Norplant and contraceptive pricing
Subtitle: conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1994
Place of publication: Washington
Language: eng
Subjects: Norgestrel -- Prices -- United States.; Contraceptives -- Prices -- United States.; Drugs -- Research -- United States.; Research and development contracts, Government -- United States.; Research and development partnership -- United States.
Notes: Includes bibliographical references.
Description based on pt. 3.
Distributed to some depository libraries in microfiche.
Shipping list no.: 94-0103-P (pt. 3).
"Washington, DC, November 10, 1993"--Pt. 3.
"Serial no. 103-59"--Pt. 3.